Status: Not yet activePhase: Phase IIIType: TreatmentAge: 18 and overTrial IDs: CA209-648, NCI-2017-00937, 2016-001514-20, NCT03143153Status: ActivePhase: Phase IIType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 16099, NCI-2016-00686, NCT02830594
